Approvals/TGA/NEBIVOLOL SANDOZ nebivolol (as hydrochloride) 1.25 mg immediate release tablet blister pack

Approved

STANDARD

NEBIVOLOL SANDOZ nebivolol (as hydrochloride) 1.25 mg immediate release tablet blister pack

Southern Cross Pharma Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2c169e6f6e2f4b1f
Product Name: NEBIVOLOL SANDOZ nebivolol (as hydrochloride) 1.25 mg immediate release tablet blister pack
Artg Id: 311723
Artg Name: NEBIVOLOL SANDOZ nebivolol (as hydrochloride) 1.25 mg immediate release tablet blister pack
Sponsor: Southern Cross Pharma Pty Ltd
Company Detail Path: /organization/southern-cross-pharma-pty-ltd
Artg Date: 2020-04-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/26a6306c864737b9c8545810934012a0.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/d15bb4167d7715c9e1e266848e77d8d3.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

2c169e6f6e2f4b1f

Type

Standard